Earnings results
Quarterly results as US companies announce them to the SEC (Form 8-K, Item 2.02), with figures from each company’s own filed statements. About half of companies file detailed figures the same day they announce; the rest show as pending until the quarterly statement arrives. No analyst estimates, no consensus: what was reported, compared with the same quarter a year earlier.
10,467 announcements in the last 12 months · page 7 of 105
| Announced | Company | Period | Revenue | Rev YoY | Net income | EPS | EPS YoY | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | Janus International Group, Inc. (JBI) | Q2 FY2026 | $233.5M | 2.4% | $10.7M | 0.08 | -46.7% | 8-K |
| 2026-08-11 | JACK HENRY & ASSOCIATES INC (JKHY) | Q4 FY2026 | $644.0M | 4.7% | $111.2M | 1.57 | -10.2% | 8-K |
| 2026-08-11 | GLADSTONE LAND Corp (LAND) | Q2 FY2026 | $12.7M | 3.2% | $-8.5M | -0.32 | — | 8-K |
| 2026-08-11 | LENZ Therapeutics, Inc. (LENZ) | Q2 FY2026 | $5.5M | 9.7% | $-31.9M | -1.02 | — | 8-K |
| 2026-08-11 | Lumentum Holdings Inc. (LITE) | Q4 FY2026 | $1.01B | 109.3% | $-7.16B | — | — | 8-K |
| 2026-08-11 | 908 Devices Inc. (MASS) | Q2 FY2026 | $16.1M | 23.3% | $-11.9M | -0.32 | — | 8-K |
| 2026-08-11 | Maze Therapeutics, Inc. (MAZE) | Q2 FY2026 | — | — | $-44.7M | -0.76 | — | 8-K |
| 2026-08-11 | MIDDLEBY Corp (MIDD) | Q2 FY2026 | $875.5M | 9.9% | $54.8M | 1.21 | -39.2% | 8-K |
| 2026-08-11 | Mount Logan Capital Inc. (MLCI) | Q2 FY2026 | $8.7M | -48.9% | $-4.2M | -0.37 | — | 8-K |
| 2026-08-11 | Mereo BioPharma Group plc (MREO) | Q2 FY2026 | $0 | -100.0% | $-7.0M | -0.01 | — | 8-K |
| 2026-08-11 | Microvast Holdings, Inc. (MVST) | Q2 FY2026 | $87.3M | -4.5% | $-12.0M | -0.03 | — | 8-K |
| 2026-08-11 | PLAYSTUDIOS, Inc. (MYPS) | Q2 FY2026 | $55.0M | -7.3% | $-13.3M | -0.10 | — | 8-K |
| 2026-08-11 | National CineMedia, Inc. (NCMI) | Q2 FY2026 | $58.4M | 12.7% | $-9.9M | -0.11 | — | 8-K |
| 2026-08-11 | NATIONAL HEALTHCARE CORP (NHC) | Q2 FY2026 | $408.0M | 8.8% | $40.3M | 2.54 | 67.1% | 8-K |
| 2026-08-11 | NeuroPace Inc (NPCE) | Q2 FY2026 | $22.8M | 17.1% | $-6.2M | -0.18 | — | 8-K |
| 2026-08-11 | Energy Vault Holdings, Inc. (NRGV) | Q2 FY2026 | $17.4M | 104.1% | $-29.7M | -0.18 | — | 8-K |
| 2026-08-11reported in filing | Brookfield Oaktree Holdings, LLC (OAK-PA) | Q2 FY2026 | $91.2M | -24.7% | $55.9M | 0.41 | 241.7% | 8-K |
| 2026-08-11 | Optex Systems Holdings Inc (OPXS) | Q3 FY2026 | $9.7M | -12.4% | $1.3M | 0.18 | -18.2% | 8-K |
| 2026-08-11 | Owlet, Inc. (OWLT) | Q2 FY2026 | $33.9M | 29.9% | $-620,000 | -0.05 | — | 8-K |
| 2026-08-11 | Prelude Therapeutics Inc (PRLD) | Q2 FY2026 | $5.7M | — | $-13.9M | -0.14 | — | 8-K |
| 2026-08-11 | Peraso Inc. (PRSO) | Q2 FY2026 | $1.3M | -41.1% | $-2.2M | -0.16 | — | 8-K |
| 2026-08-11 | PIXELWORKS, INC (PXLW) | Q2 FY2026 | $64,000 | — | $-2.8M | -0.44 | — | 8-K |
| 2026-08-11 | QUICKLOGIC Corp (QUIK) | Q2 FY2026 | $5.5M | 48.7% | $-887,000 | -0.05 | — | 8-K |
| 2026-08-11 | RideNow Group, Inc. (RDNW) | Q2 FY2026 | $296.8M | -1.0% | $6.5M | 0.16 | — | 8-K |
| 2026-08-11 | Red Violet, Inc. (RDVT) | Q2 FY2026 | $26.7M | 22.7% | $5.0M | 0.34 | 88.9% | 8-K |
| 2026-08-11 | REED'S, INC. (REED) | Q2 FY2026 | $7.5M | -21.4% | $-4.3M | -0.36 | — | 8-K |
| 2026-08-11 | High Roller Technologies, Inc. (ROLR) | Q2 FY2026 | $2.8M | -51.6% | $-2.4M | -0.22 | — | 8-K |
| 2026-08-11 | Seer, Inc. (SEER) | Q2 FY2026 | $3.1M | -23.4% | $-16.9M | — | — | 8-K |
| 2026-08-11 | SES AI Corp (SES) | Q2 FY2026 | $5.1M | 43.8% | $-17.9M | -0.05 | — | 8-K |
| 2026-08-11 | SMITHFIELD FOODS INC (SFD) | Q2 FY2026 | $3.70B | -2.3% | $238.0M | 0.60 | 25.0% | 8-K |
| 2026-08-11reported in filing | Strategic Storage Trust VI, Inc. (SGST) | Q2 FY2026 | $8.0M | 4.9% | $-9.5M | — | — | 8-K |
| 2026-08-11reported in filing | SIEBERT FINANCIAL CORP (SIEB) | Q2 FY2026 | $31.2M | 109.6% | $-326,000 | -0.01 | — | 8-K |
| 2026-08-11 | SILICON LABORATORIES INC. (SLAB) | Q2 FY2026 | $228.2M | 18.3% | $-10.6M | -0.32 | — | 8-K |
| 2026-08-11 | Stabilis Solutions, Inc. (SLNG) | Q2 FY2026 | $11.9M | -31.2% | $-4.6M | — | — | 8-K |
| 2026-08-11 | Super Micro Computer, Inc. (SMCI) | Q4 FY2026 | $11.12B | 93.2% | $1.18B | 1.53 | 401.0% | 8-K |
| 2026-08-11 | Sanara MedTech Inc. (SMTI) | Q2 FY2026 | $28.1M | 9.0% | $-452,864 | -0.05 | — | 8-K |
| 2026-08-11 | Snail, Inc. (SNAL) | Q2 FY2026 | $19.7M | -11.3% | $-3.0M | — | — | 8-K |
| 2026-08-11 | Smart Sand, Inc. (SND) | Q2 FY2026 | $115.0M | 34.1% | $10.2M | 0.25 | -53.7% | 8-K |
| 2026-08-11 | Neuronetics, Inc. (STIM) | Q2 FY2026 | $41.6M | 9.1% | $-3.4M | -0.05 | — | 8-K |
| 2026-08-11 | Stereotaxis, Inc. (STXS) | Q2 FY2026 | $7.7M | -12.8% | $-4.5M | -0.05 | — | 8-K |
| 2026-08-11 | Stran & Company, Inc. (SWAG) | Q2 FY2026 | $33.4M | 2.4% | $309,000 | 0.02 | -33.3% | 8-K |
| 2026-08-11 | TRANSACT TECHNOLOGIES INC (TACT) | Q2 FY2026 | $13.9M | 1.1% | $-50,000 | 0.00 | — | 8-K |
| 2026-08-11 | TANDY LEATHER FACTORY INC (TLF) | Q2 FY2026 | $18.0M | 1.5% | $409,000 | 0.05 | — | 8-K |
| 2026-08-11 | Tango Therapeutics, Inc. (TNGX) | Q2 FY2026 | $0 | -100.0% | $-55.3M | -0.37 | — | 8-K |
| 2026-08-11 | TON Strategy Co (TONX) | Q2 FY2026 | $15.0M | 607.4% | $76.8M | 1.31 | — | 8-K |
| 2026-08-11 | Taysha Gene Therapies, Inc. (TSHA) | Q2 FY2026 | $0 | -100.0% | $-46.6M | -0.13 | — | 8-K |
| 2026-08-11 | UNITED STATES ANTIMONY CORP (UAMY) | Q2 FY2026 | $7.9M | -24.7% | $110,290 | — | — | 8-K |
| 2026-08-11 | Velo3D, Inc. (VELO) | Q2 FY2026 | $20.7M | 52.3% | $-11.5M | -0.39 | — | 8-K |
| 2026-08-11 | Venture Global, Inc. (VG) | Q2 FY2026 | $4.58B | 47.6% | $1.42B | 0.51 | 264.3% | 8-K |
| 2026-08-11 | Vireo Growth Inc. (VREOF) | Q2 FY2026 | $209.3M | 335.1% | $-100,000 | 0.00 | — | 8-K |
| 2026-08-11 | Vestis Corp (VSTS) | Q3 FY2026 | $661.7M | -1.8% | $11.0M | 0.08 | — | 8-K |
| 2026-08-11 | Xtant Medical Holdings, Inc. (XTNT) | Q2 FY2026 | $23.0M | -35.0% | $-9.4M | -0.07 | -450.0% | 8-K |
| 2026-08-10 | AAON, INC. (AAON) | Q2 FY2026 | $627.0M | 101.2% | $56.7M | 0.68 | 257.9% | 8-K |
| 2026-08-10 | ACCENDRA HEALTH INC/VA/ (ACH) | Q2 FY2026 | $613.2M | -10.1% | $-89.1M | -1.16 | — | 8-K |
| 2026-08-10 | AECOM (ACM) | Q3 FY2026 | $3.59B | -14.2% | $-86.7M | -0.67 | -168.4% | 8-K |
| 2026-08-10 | ACV Auctions Inc. (ACVA) | Q2 FY2026 | $213.9M | 10.4% | $-8.2M | -0.05 | — | 8-K |
| 2026-08-10 | Aeries Technology, Inc. (AERT) | Q1 FY2027 | $21.9M | 43.0% | $1.9M | — | — | 8-K |
| 2026-08-10 | Powerfleet, Inc. (AIOT) | Q1 FY2027 | $110.8M | 6.4% | $-8.4M | -0.06 | — | 8-K |
| 2026-08-10 | Airsculpt Technologies, Inc. (AIRS) | Q2 FY2026 | $42.9M | -2.5% | $-1.1M | -0.02 | — | 8-K |
| 2026-08-10 | ALICO, INC. (ALCO) | Q3 FY2026 | $9.0M | 7.7% | $2.1M | 0.29 | — | 8-K |
| 2026-08-10 | AlTi Global, Inc. (ALTI) | Q2 FY2026 | $58.0M | 10.8% | $-23.5M | — | — | 8-K |
| 2026-08-10 | Amplify Energy Corp. (AMPY) | Q2 FY2026 | $52.7M | -22.9% | $17.3M | 0.40 | 166.7% | 8-K |
| 2026-08-10 | Amentum Holdings, Inc. (AMTM) | Q3 FY2026 | $3.49B | -2.0% | $66.0M | 0.27 | 575.0% | 8-K |
| 2026-08-10 | AMERICAN PUBLIC EDUCATION INC (APEI) | Q2 FY2026 | $171.7M | 5.5% | $9.8M | 0.52 | — | 8-K |
| 2026-08-10reported in filing | AMERICAN REBEL HOLDINGS INC (AREB) | Q2 FY2026 | $2.0M | -30.1% | $-6.0M | — | — | 8-K |
| 2026-08-10 | Arena Group Holdings, Inc. (AREN) | Q2 FY2026 | $22.2M | -50.7% | $-176,000 | 0.00 | -100.0% | 8-K |
| 2026-08-10 | Arena Group Holdings, Inc. (AREN) | Q2 FY2026 | $22.2M | -50.7% | $-176,000 | 0.00 | -100.0% | 8-K |
| 2026-08-10 | ARK RESTAURANTS CORP (ARKR) | Q3 FY2026 | $40.9M | -6.5% | $-347,000 | -0.10 | — | 8-K |
| 2026-08-10 | Arq, Inc. (ARQ) | Q2 FY2026 | $29.9M | 4.5% | $-733,000 | -0.02 | — | 8-K |
| 2026-08-10 | AST SpaceMobile, Inc. (ASTS) | Q2 FY2026 | $31.5M | 2626.6% | $-230.9M | — | — | 8-K |
| 2026-08-10 | Athene Holding Ltd. (ATH-PA) | Q2 FY2026 | $9.15B | 70.8% | $989.0M | — | — | 8-K |
| 2026-08-10 | Axsome Therapeutics, Inc. (AXSM) | Q2 FY2026 | $218.4M | 45.5% | $-51.3M | -0.99 | — | 8-K |
| 2026-08-10 | BridgeBio Pharma, Inc. (BBIO) | Q2 FY2026 | $243.7M | 120.4% | $-155.9M | -0.78 | — | 8-K |
| 2026-08-10 | Bain Capital Specialty Finance, Inc. (BCSF) | Q2 FY2026 | — | — | $14.1M | 0.22 | -40.5% | 8-K |
| 2026-08-10 | Brookdale Senior Living Inc. (BKD) | Q2 FY2026 | $718.6M | -11.6% | $23.3M | 0.10 | — | 8-K |
| 2026-08-10 | Bakkt, Inc. (BKKT) | Q2 FY2026 | — | — | $80.8M | 1.94 | — | 8-K |
| 2026-08-10 | Bionano Genomics, Inc. (BNGO) | Q2 FY2026 | $8.2M | 21.4% | $-7.4M | -0.64 | — | 8-K |
| 2026-08-10 | Beachbody Company, Inc. (BODI) | Q2 FY2026 | $49.6M | -22.4% | $1.4M | 0.11 | — | 8-K |
| 2026-08-10 | BRT Apartments Corp. (BRT) | Q2 FY2026 | $24.5M | 1.1% | $-3.2M | — | — | 8-K |
| 2026-08-10 | Babcock & Wilcox Enterprises, Inc. (BW) | Q2 FY2026 | $319.7M | 130.3% | $14.3M | 0.07 | — | 8-K |
| 2026-08-10 | Bowman Consulting Group Ltd. (BWMN) | Q2 FY2026 | $146.1M | 19.7% | $2.5M | 0.14 | -58.8% | 8-K |
| 2026-08-10 | Ceribell, Inc. (CBLL) | Q2 FY2026 | $28.1M | 32.5% | $-19.3M | -0.51 | — | 8-K |
| 2026-08-10 | Crescent Capital BDC, Inc. (CCAP) | Q2 FY2026 | — | — | $-3.2M | — | — | 8-K |
| 2026-08-10 | CECO ENVIRONMENTAL CORP (CECO) | Q2 FY2026 | $285.0M | 53.7% | $-34.8M | -0.80 | -407.7% | 8-K |
| 2026-08-10 | CEVA INC (CEVA) | Q2 FY2026 | $29.0M | 13.1% | $-2.9M | — | — | 8-K |
| 2026-08-10 | CONDUENT Inc (CNDT) | Q2 FY2026 | $531.0M | -11.9% | $-116.0M | -0.76 | — | 8-K |
| 2026-08-10 | Cannae Holdings, Inc. (CNNE) | Q2 FY2026 | $102.2M | -7.3% | $37.5M | 0.86 | — | 8-K |
| 2026-08-10 | Compass Diversified Holdings (CODI) | Q2 FY2026 | $424.0M | -11.4% | $81.1M | 0.86 | — | 8-K |
| 2026-08-10 | California Resources Corp (CRC) | Q2 FY2026 | $1.06B | 50.4% | $514.0M | 5.76 | 200.0% | 8-K |
| 2026-08-10 | Citi Trends Inc (CTRN) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-08-10 | Consolidated Water Co. Ltd. (CWCO) | Q2 FY2026 | $32.9M | -2.1% | $3.9M | 0.24 | -25.0% | 8-K |
| 2026-08-10 | Definitive Healthcare Corp. (DH) | Q2 FY2026 | $55.2M | -9.1% | $-5.4M | -0.05 | — | 8-K |
| 2026-08-10 | Dole plc (DOLE) | Q2 FY2026 | $2.50B | 2.9% | $26.0M | 0.27 | 170.0% | 8-K |
| 2026-08-10 | Viant Technology Inc. (DSP) | Q2 FY2026 | $104.3M | 33.9% | $-111,000 | — | — | 8-K |
| 2026-08-10 | ENANTA PHARMACEUTICALS INC (ENTA) | Q3 FY2026 | $14.4M | -21.6% | $-19.5M | -0.67 | — | 8-K |
| 2026-08-10 | Energy Services of America CORP (ESOA) | Announced; detailed figures pending the quarterly statement | 8-K | |||||
| 2026-08-10 | ENTRAVISION COMMUNICATIONS CORP (EVC) | Q2 FY2026 | $227.9M | 126.2% | $19.7M | 0.19 | — | 8-K |
| 2026-08-10 | Exodus Movement, Inc. (EXOD) | Q2 FY2026 | $26.2M | 1.6% | $-18.6M | — | — | 8-K |
| 2026-08-10reported in filing | SPECTRAL CAPITAL Corp (FCCN) | Q2 FY2026 | $318.3M | — | $7.4M | 0.08 | — | 8-K |
| 2026-08-10 | Ferguson Enterprises Inc. /DE/ (FERG) | Q4 FY2026 | $8.75B | 3.0% | $666.0M | 3.43 | -3.3% | 8-K |
Source: SEC EDGAR. Figures are as reported in each company’s filings and may be unaudited or restated; a company that announces results in more than one filing (for example a delivery report and an earnings release) appears once per filing. Most rows come from an earnings release (Form 8-K, Item 2.02). Some companies file no separate release, so their periodic report is the event and the row is marked “reported in filing”. Foreign private issuers appear only where their Form 6-K tags the financial data itself, which is a minority of them: many report half-yearly, so there is no quarter to show and they are left out rather than listed without figures. Informational only. Not investment advice.